{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:15:46Z","timestamp":1794590146329,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10815-020-01701-0","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T12:06:58Z","timestamp":1582546018000},"page":"849-854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?"],"prefix":"10.1007","volume":"37","author":[{"given":"M.","family":"Friedman-Gohas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kirshenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Michaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Domniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Elizur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"1701_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0959-437X(02)00300-3","volume":"12","author":"B Bardoni","year":"2002","unstructured":"Bardoni B, Mandel JL. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr Opin Genet Dev. 2002;12:284\u201393.","journal-title":"Curr Opin Genet Dev"},{"key":"1701_CR2","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/humrep\/13.5.1184","volume":"13","author":"GS Conway","year":"1998","unstructured":"Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998;13:1184\u20137.","journal-title":"Hum Reprod"},{"key":"1701_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","volume":"87","author":"MD Wittenberger","year":"2007","unstructured":"Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456\u201365.","journal-title":"Fertil Steril"},{"key":"1701_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1866-1955-6-23","volume":"6","author":"C Sellier","year":"2014","unstructured":"Sellier C, Usdin K, Pastori C, Peschansky VJ, Tassone F, Charlet-Berguerand N. The multiple molecular facets of fragile X-associated tremor\/ ataxia syndrome. J Neurodev Disord. 2014;6:23.","journal-title":"J Neurodev Disord"},{"key":"1701_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1056\/NEJMcp0808697","volume":"360","author":"LM Nelson","year":"2009","unstructured":"Nelson LM. Primary ovarian insufficiency. N Engl J Med. 2009;360:606\u201314.","journal-title":"N Engl J Med"},{"key":"1701_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.03073.x","volume":"68","author":"CK Welt","year":"2008","unstructured":"Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol. 2008;68:499\u2013509.","journal-title":"Clin Endocrinol"},{"key":"1701_CR7","first-page":"604","volume":"67","author":"CB Coulam","year":"1986","unstructured":"Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604\u20136.","journal-title":"Obstet Gynecol"},{"key":"1701_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/humrep\/deg005","volume":"18","author":"JL Luborsky","year":"2003","unstructured":"Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18:199\u2013206.","journal-title":"Hum Reprod"},{"key":"1701_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00439-005-1326-8","volume":"117","author":"KL Bretherick","year":"2005","unstructured":"Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117:376\u201382.","journal-title":"Hum Genet"},{"key":"1701_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/humrep\/dei432","volume":"21","author":"B Bodega","year":"2006","unstructured":"Bodega B, Bione S, Dalpr\u00e0 L, Toniolo D, Ornaghi F, Vegetti W, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006;21:952\u20137.","journal-title":"Hum Reprod"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ajmg.b.32277","volume":"165","author":"MR Mailick","year":"2014","unstructured":"Mailick MR, Hong J, Greenberg J, Smith L, Sherman S. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. Am J Med Genet B Neuropsychiatr Genet. 2014;165:705\u201311.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1701_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","volume":"20","author":"AK Sullivan","year":"2005","unstructured":"Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20:402\u201312.","journal-title":"Hum Reprod"},{"key":"1701_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/humrep\/14.5.1217","volume":"14","author":"A Murray","year":"1999","unstructured":"Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE, Conway GS. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod. 1999;14:1217\u20138.","journal-title":"Hum Reprod"},{"key":"1701_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/humrep\/16.3.457","volume":"16","author":"RD Hundscheid","year":"2001","unstructured":"Hundscheid RD, Braat DD, Kiemeney LA, Smits AP, Thomas CM. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod. 2001;16:457\u201362.","journal-title":"Hum Reprod"},{"key":"1701_CR15","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1210\/jc.2004-0347","volume":"89","author":"CK Welt","year":"2004","unstructured":"Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab. 2004;89:4569\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"1701_CR16","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1093\/humrep\/17.11.2807","volume":"17","author":"P Platteau","year":"2002","unstructured":"Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I. Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod. 2002;17:2807\u201312.","journal-title":"Hum Reprod"},{"key":"1701_CR17","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.fertnstert.2008.01.099","volume":"91","author":"N Gleicher","year":"2009","unstructured":"Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril. 2009;91:1707\u201311.","journal-title":"Fertil Steril"},{"key":"1701_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1472-6483(10)60173-3","volume":"19","author":"N Gleicher","year":"2009","unstructured":"Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod BioMed Online. 2009;19:385\u201390.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"1701_CR19","first-page":"1012","volume":"2","author":"SE Elizur","year":"2015","unstructured":"Elizur SE, Orvieto R, Cohen Y. Are we close to solve the mystery of fragile X associated premature ovarian insufficiency (FXPOI) in FMR1 premutation carriers? Austin J In Vitro Fertili. 2015;2(1):1012.","journal-title":"Austin J In Vitro Fertili"},{"issue":"4","key":"1701_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.rbmo.2018.11.009","volume":"38","author":"LM Pastore","year":"2019","unstructured":"Pastore LM, Christianson MS, McGuinness B, Vaught KC, Maher JY, Kearns WG. Does the FMR1 gene affect IVF success? Reprod BioMed Online. 2019;38(4):560\u20139.","journal-title":"Reprod BioMed Online"},{"key":"1701_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/humrep\/den050","volume":"23","author":"J Rohr","year":"2008","unstructured":"Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, et al. Anti-mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod. 2008;23:1220\u20135.","journal-title":"Hum Reprod"},{"key":"1701_CR22","first-page":"869","volume":"94","author":"G Bibi","year":"2010","unstructured":"Bibi G, Malcov M, Yuval Y, Reches A, Ben-Yosef D, Almog B, et al. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. FertilSteril. 2010;94:869\u201374.","journal-title":"FertilSteril."},{"key":"1701_CR23","doi-asserted-by":"publisher","first-page":"105121","DOI":"10.1371\/journal.pone.0105121","volume":"9","author":"SE Elizur","year":"2014","unstructured":"Elizur SE, Lebovitz O, Derech-Haim S, Dratviman-Storobinsky O, Feldman B, Dor J, et al. Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers. PLoS One. 2014;9:105121.","journal-title":"PLoS One"},{"key":"1701_CR24","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/humrep\/deq203","volume":"25","author":"A Tsafrir","year":"2010","unstructured":"Tsafrir A, Altarescu G, Margalioth E, Brooks B, Renbaum P, Levy-Lahad E, et al. PGD for fragile X syndrome: ovarian function is the main determinant of success. Hum Reprod. 2010;25:2629\u201336.","journal-title":"Hum Reprod"},{"key":"1701_CR25","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/humrep\/dex090","volume":"32","author":"S Avraham","year":"2017","unstructured":"Avraham S, Almog B, Reches A, Zakar A, Malcov M, Sokolov A, et al. The ovarian response in fragile X patients and premutation carriers undergoing IVF\u2013PGD: reappraisal. Hum Reprod. 2017;32:1508\u201311.","journal-title":"Hum Reprod"},{"key":"1701_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/gim.2014.106","volume":"17","author":"SL Nolin","year":"2015","unstructured":"Nolin SL, Glicksman A, Ersalesi N, Dobkin C, Brown WT, Cao R, et al. Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers. Genet Med. 2015;17:358\u201364.","journal-title":"Genet Med"},{"key":"1701_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1866-1955-6-24","volume":"6","author":"CM Yrigollen","year":"2014","unstructured":"Yrigollen CM, Martorell L, Durbin-Johnson B, Naudo M, Genoves J, Murgia A, et al. AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J Neurodev Disord. 2014;6:24.","journal-title":"J Neurodev Disord"},{"key":"1701_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fgene.2018.00606","volume":"9","author":"N Domniz","year":"2018","unstructured":"Domniz N, Ries-Levavi L, Cohen Y, Marom-Haham L, Berkenstadt M, Pras E, et al. Absence of AGG interruptions is a risk factor for full mutation expansion among Israeli FMR1 premutation carriers. Front Genet. 2018;9:606.","journal-title":"Front Genet"},{"issue":"2","key":"1701_CR29","first-page":"370","volume":"31","author":"P Drakopoulos","year":"2016","unstructured":"Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, et al. Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31(2):370\u20136.","journal-title":"Hum Reprod"},{"key":"1701_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ejhg.5201510","volume":"14","author":"S Ennis","year":"2006","unstructured":"Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet. 2006;14:253\u20135.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"1701_CR31","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/gme.0b013e3181647762","volume":"15","author":"MI Tejada","year":"2008","unstructured":"Tejada MI, Garc\u00eda-Alegr\u00eda E, Bilbao A, Mart\u00ednez-Bouzas C, Beristain E, Poch M, et al. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause. 2008;15(5):945\u20139.","journal-title":"Menopause"},{"key":"1701_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/nar\/gki186","volume":"33","author":"M Napierala","year":"2005","unstructured":"Napierala M, Michalowski D, de Mezer M, Krzyzosiak WJ. Facile FMR1 mRNA structure regulation by interruptions in CGG repeats. Nucleic Acids Res. 2005;33:451\u201363.","journal-title":"Nucleic Acids Res"},{"key":"1701_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/gim.2017.220","volume":"20","author":"J Lekovich","year":"2018","unstructured":"Lekovich J, Man L, Xu K, Canon C, Lilientha D, Stewart JD, et al. CGG repeat length and AGG interruptions as indicators of fragile X\u2013associated diminished ovarian reserve. Genet Med. 2018;20:957\u201364.","journal-title":"Genet Med"},{"key":"1701_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fgene.2018.00292","volume":"9","author":"EG Allen","year":"2018","unstructured":"Allen EG, Glicksman A, Tortora N, Charen K, He W, Amin A, et al. FXPOI: pattern of AGG interruptions does not show an association with age at amenorrhea among women with premutation. Front Genet. 2018;9:292.","journal-title":"Front Genet"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01701-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-020-01701-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01701-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:34:15Z","timestamp":1614040455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-020-01701-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s10815-020-01701-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Research and Ethical Committee of the Sheba Medical Center (Tel Hashomer), Ramat-Gan, Israel.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}